ArticleBone marrow transplantation2026

Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD.

Jean Caputo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.